Zeitschrift für medizinische und chirurgische Pathologie
Offener Zugang

Abstrakt

Use of Sargramostim Drug in Alzheimer Patients for Memory Improvement

Sudha Jimson

Alzheimer's disease is a neurologic disorder that causes the brain to shrink (atrophy) and the death of brain cells. It is the most common cause of dementia, which is defined as a progressive loss of cognitive, behavioural, and social abilities that impairs a person's ability to function independently. Sargramostim is a yeast-expressed human recombinant granulocyte macrophage colony-stimulating factor (GM-CSF). It has 127 residues and is a glycoprotein